• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于慢性细菌性前列腺炎小鼠模型的不同纳米颗粒对前列腺组织的靶向能力

targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis.

作者信息

Hu Ruimin, Yang Yang, Song Guojing, Zhao Fuhan, Chen Saipeng, Zhou Zhansong, Zheng Jun, Shen Wenhao

机构信息

Department of Urology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.

出版信息

Front Bioeng Biotechnol. 2022 Oct 6;10:1021385. doi: 10.3389/fbioe.2022.1021385. eCollection 2022.

DOI:10.3389/fbioe.2022.1021385
PMID:36277385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9582453/
Abstract

Chronic bacterial prostatitis usually occurs in men and seriously affects the quality of life of patients. The efficacy of chronic bacterial prostatitis treatment is limited by the difficulty for free drugs (e.g., antibiotics) to penetrate the prostate epithelium and target inflammatory tissues. The advent of nanotechnology offers the possibility to address this issue, such as the development of targeted nanoparticle delivery strategies that may overcome these important limitations. The physicochemical properties of nanoparticles, such as particle size, shape and surface modification ligands, determine their targeting effectiveness. In this study, nanoparticles with different physicochemical properties were prepared to explore and confirm their targeting capacities to inflammatory prostate tissues of chronic bacterial prostatitis, focusing on the effects of size and different modification ligands on the targeting performance. and imaging results verified that folic acid-modified nanoparticles with a particle size of 180-190 nm via tail intravenous injection had the optimal targeting efficiency to prostate tissues. Our results provide an experimental basis and reference value for targeted therapy of prostate-related diseases with nanotechnology in the future.

摘要

慢性细菌性前列腺炎通常发生在男性身上,严重影响患者的生活质量。慢性细菌性前列腺炎的治疗效果受到游离药物(如抗生素)难以穿透前列腺上皮并靶向炎症组织的限制。纳米技术的出现为解决这一问题提供了可能性,例如开发靶向纳米颗粒递送策略,可能克服这些重要限制。纳米颗粒的物理化学性质,如粒径、形状和表面修饰配体,决定了它们的靶向效果。在本研究中,制备了具有不同物理化学性质的纳米颗粒,以探索并确认它们对慢性细菌性前列腺炎炎症前列腺组织的靶向能力,重点关注粒径和不同修饰配体对靶向性能的影响。成像结果证实,通过尾静脉注射的粒径为180 - 190 nm的叶酸修饰纳米颗粒对前列腺组织具有最佳靶向效率。我们的结果为未来利用纳米技术对前列腺相关疾病进行靶向治疗提供了实验依据和参考价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dde1/9582453/d4e7f24828ad/fbioe-10-1021385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dde1/9582453/d4e7f24828ad/fbioe-10-1021385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dde1/9582453/d4e7f24828ad/fbioe-10-1021385-g001.jpg

相似文献

1
targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis.基于慢性细菌性前列腺炎小鼠模型的不同纳米颗粒对前列腺组织的靶向能力
Front Bioeng Biotechnol. 2022 Oct 6;10:1021385. doi: 10.3389/fbioe.2022.1021385. eCollection 2022.
2
Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.负载抗生素的活性氧响应性纳米药物用于慢性细菌性前列腺炎的有效管理。
Acta Biomater. 2022 Apr 15;143:471-486. doi: 10.1016/j.actbio.2022.02.044. Epub 2022 Mar 5.
3
Multidisciplinary approach to prostatitis.前列腺炎的多学科治疗方法。
Arch Ital Urol Androl. 2019 Jan 18;90(4):227-248. doi: 10.4081/aiua.2018.4.227.
4
Therapeutic Applications of Functional Nanomaterials for Prostatitis.功能性纳米材料在前列腺炎治疗中的应用
Front Pharmacol. 2021 May 28;12:685465. doi: 10.3389/fphar.2021.685465. eCollection 2021.
5
[Penetrability of amikacin into prostate tissues in rat models of chronic bacterial prostatitis].[阿米卡星在慢性细菌性前列腺炎大鼠模型中进入前列腺组织的穿透性]
Zhonghua Nan Ke Xue. 2008 Jul;14(7):583-9.
6
Anti-inflammatory and antioxidant effect of modified Bazhengsan in a rat model of chronic bacterial prostatitis.加味八正散对慢性细菌性前列腺炎大鼠模型的抗炎和抗氧化作用
J Ethnopharmacol. 2017 Feb 23;198:73-80. doi: 10.1016/j.jep.2016.12.039. Epub 2016 Dec 22.
7
CHRONIC PROSTATITIS THERAPY COMBINED WITH ELECTROMYOSTIMULATION-ASPIRATION, TRANSURETHRAL ELECTROPHONOPHORESIS OF PLATELET-RICH PLASMA AND TRANSRECTAL LOW-INTENSITY PULSED ULTRASOUND.慢性前列腺炎治疗联合肌电刺激抽吸、经尿道富血小板血浆电声透入疗法及经直肠低强度脉冲超声治疗
Georgian Med News. 2020 Feb(299):29-33.
8
In vivo targeted delivery of nanoparticles for theranosis.体内靶向递纳米粒用于治疗。
Acc Chem Res. 2011 Oct 18;44(10):1018-28. doi: 10.1021/ar2000138. Epub 2011 Aug 18.
9
Recent advances in improving tumor-targeted delivery of imaging nanoprobes.改善肿瘤靶向递送成像纳米探针的最新进展。
Biomater Sci. 2020 Aug 7;8(15):4129-4146. doi: 10.1039/d0bm00761g. Epub 2020 Jul 8.
10
Identification, pharmacologic considerations, and management of prostatitis.前列腺炎的识别、药理学考量及管理
Am J Geriatr Pharmacother. 2011 Feb;9(1):37-48. doi: 10.1016/j.amjopharm.2011.02.005.

引用本文的文献

1
Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis.用于治疗慢性细菌性前列腺炎的靶向环丙沙星纳米载体的制备与应用
Int J Pharm X. 2024 Apr 18;7:100247. doi: 10.1016/j.ijpx.2024.100247. eCollection 2024 Jun.
2
Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis.载大黄素的三重靶向纳米热敏水凝胶用于直肠给药系统治疗慢性非细菌性前列腺炎。
J Nanobiotechnology. 2024 Jan 18;22(1):33. doi: 10.1186/s12951-023-02282-7.
3
A combined electrohydrodynamic atomization method for preparing nanofiber/microparticle hybrid medicines.

本文引用的文献

1
Liquid exfoliation of VC nanodots as peroxidase-like nanozymes for photothermal-catalytic synergistic antibacterial treatment.VC 纳米点的液相剥离及其作为过氧化物酶样纳米酶用于光热-催化协同抗菌治疗。
Acta Biomater. 2022 Sep 1;149:359-372. doi: 10.1016/j.actbio.2022.06.031. Epub 2022 Jun 30.
2
Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.负载抗生素的活性氧响应性纳米药物用于慢性细菌性前列腺炎的有效管理。
Acta Biomater. 2022 Apr 15;143:471-486. doi: 10.1016/j.actbio.2022.02.044. Epub 2022 Mar 5.
3
Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury.
一种用于制备纳米纤维/微粒混合药物的组合式电流体动力学雾化方法。
Front Bioeng Biotechnol. 2023 Nov 15;11:1308004. doi: 10.3389/fbioe.2023.1308004. eCollection 2023.
内皮细胞靶向、ROS超敏药物/小干扰RNA共递送纳米复合物减轻早期中性粒细胞募集,用于心肌缺血再灌注损伤的抗炎治疗。
Acta Biomater. 2022 Apr 15;143:344-355. doi: 10.1016/j.actbio.2022.02.018. Epub 2022 Feb 19.
4
Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.仿生粒子工程用于非侵入式肺部吸入药物传递。
Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112324. doi: 10.1016/j.msec.2021.112324. Epub 2021 Jul 15.
5
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.叶酸修饰的 ROS 响应性纳米粒子包载木犀草素用于靶向乳腺癌治疗。
Drug Deliv. 2021 Dec;28(1):1695-1708. doi: 10.1080/10717544.2021.1963351.
6
Inorganic nanomaterials with rapid clearance for biomedical applications.用于生物医学应用的具有快速清除能力的无机纳米材料。
Chem Soc Rev. 2021 Aug 7;50(15):8669-8742. doi: 10.1039/d0cs00461h. Epub 2021 Jun 22.
7
Copper single-atom catalysts with photothermal performance and enhanced nanozyme activity for bacteria-infected wound therapy.具有光热性能和增强纳米酶活性的铜单原子催化剂用于细菌感染伤口治疗。
Bioact Mater. 2021 Apr 30;6(12):4389-4401. doi: 10.1016/j.bioactmat.2021.04.024. eCollection 2021 Dec.
8
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.利用替代策略增强纳米颗粒递送至实体瘤。
Chem Rev. 2021 Feb 10;121(3):1746-1803. doi: 10.1021/acs.chemrev.0c00779. Epub 2021 Jan 14.
9
Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization.通过巨噬细胞凋亡和再极化用于类风湿性关节炎治疗的靶向银纳米颗粒
Biomaterials. 2021 Jan;264:120390. doi: 10.1016/j.biomaterials.2020.120390. Epub 2020 Sep 19.
10
Biodegradable Nickel Disulfide Nanozymes with GSH-Depleting Function for High-Efficiency Photothermal-Catalytic Antibacterial Therapy.具有谷胱甘肽消耗功能的可生物降解二硫化镍纳米酶用于高效光热催化抗菌治疗
iScience. 2020 Jul 24;23(7):101281. doi: 10.1016/j.isci.2020.101281. Epub 2020 Jun 16.